Executive Director, Asset Team Lead

Added
2 minutes ago
Type
Full time
Salary
Upgrade to Premium to se...

Related skills

oncology clinical development phd drug discovery immunology
JobCopilot logo
Meet JobCopilot: Your Personal Al Job Hunter
Automatically Apply to Your Dream Jobs While You Sleep
Try it now β†’

πŸ“‹ Description

  • Define and drive asset strategy for small-molecule clinical programs in oncology and
  • Integrate competitive positioning, mechanistic differentiation, biomarker strategy, and patient
  • Support go/no-go, prioritization, and portfolio decisions by translating complex scientific and
  • Leverage computational approaches, proprietary data, and AI-enabled insights to strengthen asset
  • Develop and pressure-test competitive narratives for portfolio assets, building evidence to inform
  • Partner with leaders across clinical development, discovery, platform, ClinTech, business

🎯 Requirements

  • PhD in life sciences or a related scientific discipline, with deep expertise in drug discovery and
  • 10+ years of experience in biotechnology or pharmaceutical organizations.
  • Proven track record of asset-level strategic leadership and advancing programs through clinical
  • Deep expertise in the development of small-molecule therapeutics for oncology and
  • Experience in rare disease is a plus.
  • Demonstrated ability to use computational approaches and data-driven platforms to strengthen asset

🎁 Benefits

  • Remote position based in the United States.
  • Required periodic travel.
  • Annual base salary of $287,900–$356,400 for New York City, Boston, and San Francisco Bay Area
  • Annual base salary of $261,800–$314,600 for Salt Lake City and all other U.S. locations.
  • Annual bonus eligibility.
  • Equity compensation.
Share job

Meet JobCopilot: Your Personal AI Job Hunter

Automatically Apply to Data Jobs. Just set your preferences and Job Copilot will do the rest β€” finding, filtering, and applying while you focus on what matters.

Related Data Jobs

See more Data jobs β†’